| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/26/2007 | DE102006003443A1 Asparagin-10-substituierte Nonadepsipeptide Asparagine-10-substituted nonadepsipeptides |
| 07/26/2007 | DE102005055944A1 Neue cyclische Iminopeptid-Derivate und ein Verfahren zur Herstellung von cyclischen Iminopeptid-Derivate Iminopeptid novel cyclic derivatives, and a process for the preparation of cyclic derivatives Iminopeptid |
| 07/26/2007 | CA2637833A1 Pharmaceutical composition, food or drink, or feed for intestinal disease |
| 07/26/2007 | CA2637698A1 Medicament for treatment of a tumor comprising a endostatin and polyethylene glycol conjugate |
| 07/26/2007 | CA2637697A1 Means and methods for modulating stem cell mobilization |
| 07/26/2007 | CA2637687A1 Arginine deiminase conjugate for the treatment of tumours |
| 07/26/2007 | CA2637569A1 Pharmaceutical compositions with enhanced stability |
| 07/26/2007 | CA2637540A1 Isolated organ perfusion combination therapy of cancer |
| 07/26/2007 | CA2637387A1 Specific therapy using integrin ligands for treating cancer |
| 07/26/2007 | CA2636991A1 Intraventricular enzyme delivery for lysosomal storage diseases |
| 07/26/2007 | CA2636692A1 Method for treating huntington's disease by inhibiting dephosphorylation of huntingtin at s421 |
| 07/26/2007 | CA2636438A1 Intraventricular protein delivery for amyotrophic lateral sclerosis |
| 07/26/2007 | CA2636284A1 Methods of preparing activated polymers having alpha nitrogen groups |
| 07/26/2007 | CA2636111A1 Codon optimized il- 15 and il- 15r-alpha genes for expression in mammalian cells |
| 07/26/2007 | CA2633844A1 Novel fsh glycosylation variant d3n |
| 07/25/2007 | EP1811035A1 Aspartic proteinase 2 (ASP2) |
| 07/25/2007 | EP1811033A1 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 07/25/2007 | EP1811025A1 Mutated amyloid protein |
| 07/25/2007 | EP1811020A1 Escherichia coli phytase |
| 07/25/2007 | EP1810969A1 Aryloxy-substituted benzimidazole derivatives |
| 07/25/2007 | EP1810696A1 Gene therapy for treatment of cardiac failure |
| 07/25/2007 | EP1810691A2 Immunotherapy for reversing immune suppression |
| 07/25/2007 | EP1810687A1 Liver regeneration/repair controlling agent |
| 07/25/2007 | EP1810686A1 Means and methods for modulating stem cell mobilization |
| 07/25/2007 | EP1810685A1 Use of dimer-specific nuclear localisation signal peptides (dsNLS) derived from the STAT DNA binding domain |
| 07/25/2007 | EP1810675A1 Method for treating Huntington's disease by inhibiting dephosphorylation of huntingtin at S421 |
| 07/25/2007 | EP1810028A2 Heterocyclic inhibitors of ires-mediated translation and methods of use thereof |
| 07/25/2007 | EP1809761A2 Compositions and methods for modulating dhr96 |
| 07/25/2007 | EP1809742A2 Methods for treating conditions associated with the accumulation of excess extracellular matrix |
| 07/25/2007 | EP1809674A1 Process for producing natural immunobiotic extract and uses thereof |
| 07/25/2007 | EP1809667A1 Peptides for use in the treatment of obesity |
| 07/25/2007 | EP1809665A2 Mc4r selective peptides and their use in the treatment of obesity |
| 07/25/2007 | EP1809663A1 Method for purifying fsh |
| 07/25/2007 | EP1809662A2 Deamidated interferon-beta |
| 07/25/2007 | EP1809657A1 Cyclic nonapeptide amides |
| 07/25/2007 | EP1809656A2 Cyclosporin alkyne analogues and their pharmaceutical uses |
| 07/25/2007 | EP1809654A1 Heterocyclyl-substituted nonadepsipeptides |
| 07/25/2007 | EP1809653A1 Substituted nonadepsipeptides |
| 07/25/2007 | EP1809652A2 Novel topical application agents against mimic and age-related wrinkles |
| 07/25/2007 | EP1809335A2 Gastric inhibitory polypeptide (gip) antigen arrays and uses thereof |
| 07/25/2007 | EP1809331A2 Transepithelial delivery of peptides with incretin hormone activities |
| 07/25/2007 | EP1809322A2 Domain ii mutants of anthrax lethal factor |
| 07/25/2007 | EP1809320A1 Compositions containing lipase; protease and amylase for treating pancreatic insufficiency |
| 07/25/2007 | EP1809319A2 Anti-respiratory syncytial virus antibodies, antigens and uses thereof |
| 07/25/2007 | EP1809318A2 Treatment of short bowel syndrome patients with colon-in-continuity |
| 07/25/2007 | EP1809317A1 Method and pharmaceutical composition for preventing or treating diseases associated with inflammation |
| 07/25/2007 | EP1809316A1 Use of survivin to treat kidney failure |
| 07/25/2007 | EP1809315A1 Inhibition of tumor growth and metastasis by atf2-derived peptides |
| 07/25/2007 | EP1809314A2 Class iii slrp for the treatment of cancer |
| 07/25/2007 | EP1809313A2 Method to promote wound healing |
| 07/25/2007 | EP1809267A1 Pharmaceutical compositions based on nk2 antagonists for pediatric use |
| 07/25/2007 | EP1809264A2 Antimicrobial amorphous compositions |
| 07/25/2007 | EP1809238A2 Ophthalmic emulsions containing an immunosuppressive agent |
| 07/25/2007 | EP1809098A1 Methods for increasing the diversity of monoclonal antibodies produced against an antigen |
| 07/25/2007 | EP1496076B1 Hydrophilic polymer derivate with y type branch and preparation method of it medical composite comprising above compound |
| 07/25/2007 | EP1461000A4 Materials and methods for making improved micelle compositions |
| 07/25/2007 | EP1427383B1 Compositions and methods relating to prevention of chemotherapy-induced alopecia |
| 07/25/2007 | EP1389125A4 Cross-linked gelatin composition comprising a wetting agent |
| 07/25/2007 | EP1383502A4 Compounds and methods for the treatment of urogenital disorders |
| 07/25/2007 | EP1365765B1 The use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment |
| 07/25/2007 | EP1355660B1 Composition and kit for use in the treatment of tumors |
| 07/25/2007 | EP1351706B1 Factor xiii in combination with factor ix for treating hemophilia b |
| 07/25/2007 | EP1299100B1 Method of treating hot flashes, using tachykinin receptor antagonist |
| 07/25/2007 | EP1286686B1 E-selectin for treating or preventing stroke |
| 07/25/2007 | EP1286664B1 Combination of low dose estrogen and immunotherapeutic agent for treating immune diseases |
| 07/25/2007 | EP1189622B1 Anionic polymers as toxin binders and antibacterial agents |
| 07/25/2007 | EP1148129B1 Betacellulin modification |
| 07/25/2007 | EP1069912B1 Injectable igf-formulations containing succinate as buffering agent |
| 07/25/2007 | EP1042365B1 Compounds and methods for modulating occludin related tissue permeability |
| 07/25/2007 | EP1032592B1 Antimicrobial peptides |
| 07/25/2007 | EP0824546B1 Angiostatin fragments and methods of use |
| 07/25/2007 | EP0698092B1 Antisense oligonucleotides which combat aberrant splicing and methods of using the same |
| 07/25/2007 | EP0676965B1 Method of reducing immunogenicity of variable region of antibodies |
| 07/25/2007 | EP0665888B2 Ryegrass pollen allergen |
| 07/25/2007 | CN1328381C GnRH-leukotoxin chimeras |
| 07/25/2007 | CN1328377C An allelomorphic gene of gene LAPTM 4B relevant to liver cancer of human, coded result and application |
| 07/25/2007 | CN1328376C Vascular endothelial cell growth factor variants and use thereof |
| 07/25/2007 | CN1328286C Aglyco products and method of use |
| 07/25/2007 | CN1328285C Inhibitor of stem cell proliferation and uses thereof |
| 07/25/2007 | CN1328279C Viral inhibitors |
| 07/25/2007 | CN1328260C Beta crystalline form of perindopril tert-butylamine salt, preparation method and pharmaceutical compositions containing same |
| 07/25/2007 | CN1328259C Alpha crystalline form of perindopril tert-butyllamine salt |
| 07/25/2007 | CN1328258C Gamma crystalline form of perindopril tert-butylamine salt, preparation method and pharmaceutical compositions containing same |
| 07/25/2007 | CN1327905C Hemostatic dressing |
| 07/25/2007 | CN1327899C Gene recombined medicine of adenovirus carrier and p53 gene for treating proliferative diseases |
| 07/25/2007 | CN1327897C Peptide derivative fusion inhibitors of HIV infection |
| 07/25/2007 | CN1327896C Compositions and method for treating viral infections |
| 07/25/2007 | CN1327893C Use of collagenase to facilitate guide wire crossing in total arterial occlusions |
| 07/25/2007 | CN1327851C Preparation process of hepatic cell growth promotion protein and its injection preparation method |
| 07/25/2007 | CN1327827C Coated granules based on angiotensin-converting enzyme inhibitor |
| 07/25/2007 | CN1327826C Treatment of vascular thrombosis and restenosis with inhaled nitric oxide |
| 07/25/2007 | CN101006175A Modified vitamin k dependent polypeptides |
| 07/25/2007 | CN101006098A Compounds for proteasome enzyme inhibition |
| 07/25/2007 | CN101006097A Vla－4拮抗剂 Vla-4 antagonists |
| 07/25/2007 | CN101006096A Synthetic chemokines, methods of manufacture, and uses |
| 07/25/2007 | CN101005853A Therapeutic composition with a botulinum neurotoxin |
| 07/25/2007 | CN101005852A Food ingredients and food products treated with an oxidoreductase and methods for preparing such food ingredients and food products |
| 07/25/2007 | CN101005851A PTH-containing preparation for transmucosal administration |
| 07/25/2007 | CN101005850A Methods of using apo2l receptor agonists and nk cell activators |
| 07/25/2007 | CN101005849A Nutritional compositions and methods for treating or preventing osteoporosis |